Chargement en cours...
JAK2 Inhibitors: What’s the true therapeutic potential?
Physicians treating patients with the classic Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs) (polycythemia vera [PV], essential thrombocythemia [ET] and primary myelofibrosis [PMF]) traditionally had few therapeutic drugs available. Spurred by the discovery of activating mutat...
Enregistré dans:
| Publié dans: | Blood Rev |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406394/ https://ncbi.nlm.nih.gov/pubmed/21095048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2010.10.004 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|